New Cancer Treatment Adds to Survival Rates in Lung Cancer Patients
Patients with inoperable non-small cell lung cancer who receive an initial high dose of chemotherapy before their treatment begins can expect an increase in overall survival, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
This entry was posted on Thursday, June 28th, 2007 at 8:55 pm and is filed under Research, Non-Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.